Yanai Shlomo 4
4 · Amneal Pharmaceuticals, Inc. · Filed May 14, 2024
Insider Transaction Report
Form 4
Yanai Shlomo
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-05-10−76,453→ 0 total→ Class A Common Stock (76,453 underlying) - Exercise/Conversion
Class A Common Stock
2024-05-10+76,453→ 245,727 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024.